Patent directory · USPTO A61K / A61P
Patents matching “TAKEDA GMBH”
41 pharma patents match "TAKEDA GMBH" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 41 pharmaceutical patents matching "TAKEDA GMBH" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8754108
Freeze-dried pantoprazole preparation and pantoprazole injection
granted -
US 8703192
Dosage form containing pantoprazole as active ingredient
granted -
US 8663694
Taste masked dosage form containing roflumilast
granted -
US 8648100
Roflumilast for the treatment of pulmonary hypertension
granted -
US 8618142
Process for the preparation of roflumilast
granted -
US 8609848
Pyrazolone-derivatives and their use as PDE-4 inhibitors
granted -
US 8604064
Process for the preparation of roflumilast
granted -
US 8541456
Roflumilast for the treatment of diabetes mellitus type 2
granted -
US 8536206
Process for the preparation of roflumilast
granted -
US 8486923
Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
granted -
US 8481516
Ciclesonide containing sterile aqueous suspension
granted -
US 8465767
Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles
granted -
US 8455653
Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
granted -
US 8445501
Substituted 7-carboxamido-pyrrolo[3,2-d]pyrimidines
granted -
US 8440210
Stabilized pharmaceutical product
granted -
US 8435497
Formoterol of and ciclesonide combination
granted -
US 8431154
Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient
granted